COMP <GO>
AGIO vs SDGR // NET PROFIT MARGIN
Agios Pharmaceuticals Inc. (NASDAQ) VS. Schrodinger Inc. (NASDAQ) • 15-METRIC TALLY: AGIO 4
— SDGR 5
▲ NET PROFIT MARGIN LEADER: SDGR
LAST: $30.55 (-17.94%) • MKT CAP: $2.22B
net-margins
-60.00%
LAST: $27.14 (-9.50%) • MKT CAP: $2.24B
net-margins
-40.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AGIO VS. SDGR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AGIO | SDGR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 88.30% | 55.70% | +32.60 | AGIO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -33.80% | -35.00% | +1.20 | AGIO | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -16.97% | 0.56% | -17.53 | SDGR | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -60.00% | -40.40% | -19.60 | SDGR | /net-margins <GO> |
| Revenue Growth (YoY) | 48.00% | 23.30% | +24.70 | AGIO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 11.84 | 2.64 | +9.20 | AGIO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | SDGR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.6 | 59.3 | -2.70 | SDGR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.22B | $2.24B | -$20.7M | SDGR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AGIO REV | SDGR REV | AGIO GROSS % | SDGR GROSS % | AGIO FCF | SDGR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $54.0M | $255.9M | 88.3% | 55.7% | -$377.3M | $12.5M |
| FY 2024 | $36.5M | $207.5M | 88.6% | 63.6% | -$391.5M | -$164.7M |
| FY 2023 | $26.8M | $216.7M | — | — | -$296.1M | -$136.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AGIO // BETA —
SDGR // BETA —